MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2016 International Congress

    A novel phenotype of amyloid precursor protein (APP) mutation presenting with dementia, and symptoms of both progressive supranulcear palsy (PSP) and multisystem atrophy (MSA)

    J.E. Staisch, M. Padmanaban, J. Mastrianni, T. Xie (Chicago, IL, USA)

    Objective: To describe the novel phenotype of a patient with an amyloid precursur protein (APP) mutation presenting with dementia and symptoms of both progressive supranulcear…
  • 2016 International Congress

    Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum

    B. Bergmans, O. Deryck, R. Bruffaerts (Brugge, Belgium)

    Objective: Clinical characterization of a tauopathy spectrum patient. Background: In recent years phenotypic overlap has been demonstrated between patients with progressive supranuclear palsy (PSP) pathology…
  • 2016 International Congress

    Multimodal voxel-based analysis of the infratentorial brain region in Richardson’s syndrome, progressive supranuclear palsy-parkinsonism, Parkinson variant of multiple system atrophy and Parkinson’s disease

    M. Seki, C. Müller, E. Reiter, M. Nocker, M. Schocke, E. Gizewski, C. Kremser, G. Wenning, W. Poewe, K. Seppi, C. Scherfler (Innsbruck, Austria)

    Objective: Voxel-based analysis was applied to MRI parameters of iron content (transverse relaxation rate, R2*), microstructural integrity including mean diffusivity (MD) and fractional anisotropy (FA)…
  • 2016 International Congress

    Effectiveness of Levodopa responsiveness of Blink reflex recovery: An objective method to differentiate Parkinsonian syndromes

    C. Gaddipati, M. Umaiorubahan, C.U. Velmurugendran, V. Shankar (Chennai, India)

    Objective: We attempted to find an objective tool by assessing the variability of levodopa induced change in the blink reflex recovery to differentiate Parkinsonian syndromes.…
  • 2016 International Congress

    Imaging correlates of hypodipsia in progressive supranuclear palsy

    G. Respondek, T. Conrad, I. Riederer, T. Reeß, G. Rus, K. Koch, G. Höglinger, C. Zimmer (Munich, Germany)

    Objective: Aims of the present study were• to confirm hypodipsia as a characteristic feature of PSP and• to offer hypothesis on the pathological substrate for…
  • 2016 International Congress

    Oxysterol and chitotriosidase as biomarkers for atypical Parkinsonian symptoms?

    M. Schuberth, G. Nübling, J. Hauer, T. Marquardt, S. Lorenzl (München, Germany)

    Objective: The aim of the study is to establish chitotriosidase and oxysterols as a biomarker for atypical Parkinsonian syndromes in order to make a distinction…
  • 2016 International Congress

    Prevalence and incidence of PSP and CBS: A new prospective study in the UK

    J.B. Rowe, I.T. Coyle-Gilchrist (Cambridge, United Kingdom)

    Objective: To estimate the prevalence and incidence of progressive supranuclear palsy (PSP, 'Richardson's syndrome') and corticobasal syndromes (CBS); in the context of all clinical phenotypes…
  • 2016 International Congress

    Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia

    E.P.F. Resende, P. Caramelli, F.E.C. Cardoso, H.C. Guimarães, M. Hornberger, M. Bertoux, A.L. Teixeira, L. Cruz de Souza (Belo Horizonte, Brazil)

    Objective: To explore the cognitive profile of PSP patients in tests of social cognition and to compare their performance to patients with behavioural variant frontotemporal…
  • 2016 International Congress

    A longitudinal observational study of a cohort of patients with PSP/CBD: The JALPAC project

    T. Tokuda, T. Ikeuchi, H. Takigawa, I. Aiba, T. Shimohata, M. Morita, O. Onodera, S. Murayama, K. Nakashima (Kyoto, Japan)

    Objective: To identify PSP/CBD progression biomarkers both to improve understanding of disease etiology and course, and to provide crucial tools to enhance the likelihood of…
  • 2016 International Congress

    Subjective report does not predict objective swallow impairment in atypical Parkinsonian syndromes

    L. Shahgholi, S. De Jesus, A. Paterson, W. Deeb, N.R. McFarland, K. Hegland (Gainesville, FL, USA)

    Objective: Swallow and speech disturbances are common in patients with atypical parkinsonism. The emergence of swallowing problems, or dysphagia, is associated with increased morbidity and…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley